Table 2

Estimated 5- and 10-Year Survival for BARI Randomized Patients by Assigned Treatment and by Treated Diabetes Status

All PatientsPatients Without Treated DiabetesPatients With Treated Diabetes
PTCA, % (n = 915)CABG, % (n = 914)Relative RiskLog Rank p ValuePTCA, % (n = 742)CABG, % (n = 734)Relative RiskLog Rank p ValuePTCA, % (n = 173)CABG, % (n = 180)Relative RiskLog Rank p Value
Survival
 5 yr86.389.21.2791.091.451.0566.579.91.67
 10 yr71.073.51.090.1877.077.31.010.5945.557.91.290.025
Survival and freedom from Q-wave MI
 5 yr79.080.51.0883.383.41.0160.768.81.26
 10 yr63.963.60.990.9769.167.60.950.7341.447.21.110.28
Cardiac survival
 5 yr91.995.01.6295.195.71.1477.591.72.71
 10 yr85.387.71.200.2589.889.70.990.8564.479.01.700.008
Cardiac survival and freedom from any MI
 5 yr79.982.21.1383.383.81.0365.075.91.45
 10 yr68.971.11.080.5873.873.30.980.6546.161.41.400.026

MI = myocardial infarction; other abbreviations as in Table 1.

  • Relative risk for PTCA versus CABG at 5 years and at 10 years.

  • p value for the log rank statistic comparing PTCA versus CABG based on 10-year follow-up data.